1.Nicolau's Syndrome Complicated by Atypical Necrotizing Fasciitis.
Francesco SEGRETO ; Daniele TOSI ; Giovanni Francesco MARANGI ; Pierluigi GIGLIOFIORITO ; Alfonso Luca PENDOLINO ; Paolo PERSICHETTI
Archives of Plastic Surgery 2013;40(3):267-268
No abstract available.
Fasciitis, Necrotizing
2.Thromboprophylaxis in Abdominoplasty: Efficacy and Safety of a Complete Perioperative Protocol.
Giovanni Francesco MARANGI ; Francesco SEGRETO ; Igor POCCIA ; Stefano CAMPA ; Daniele TOSI ; Daniela LAMBERTI ; Paolo PERSICHETTI
Archives of Plastic Surgery 2016;43(4):360-364
BACKGROUND: Venous thromboembolism, a spectrum of diseases ranging from deep venous thrombosis to pulmonary embolism, is a major source of morbidity and mortality. The majority of cases described in plastic surgery involve abdominoplasty. Risk assessment and prophylaxis are paramount in such patients. General recommendations were recently developed, but the evidence in the literature was insufficient to prepare exhaustive guidelines regarding the medication, dosage, timing, or length of the prophylaxis. METHODS: A thromboprophylaxis protocol was developed for patients undergoing abdominoplasty. The protocol consisted of preoperative, intraoperative, and postoperative measures. Enoxaparin was administered as chemoprophylaxis in selected patients. The study involved 253 patients. The patients were analyzed for age, body mass index, enoxaparin dosage, risk factors, and complications. RESULTS: Deep venous thrombosis was documented in two cases (0.8%). No pulmonary embolism occurred. Three patients (1.2%) presented mild subcutaneous abdominal hematoma within the first postoperative week that spontaneously resorbed with neither aesthetic nor functional complications. Two patients (0.8%) presented severe hematoma requiring surgical re-intervention for drainage and hemostasis revision. Statistical analysis showed no significant correlation between enoxaparin dosage and hematoma (P=0.18) or deep venous thrombosis (P=0.61). CONCLUSIONS: The described thromboprophylaxis protocol proved to be effective in the prevention of thrombotic events, with an acceptable risk of hemorrhagic complications. Furthermore, it provides new evidence regarding the currently debated variables of chemoprophylaxis, namely type, dosage, timing, and length.
Abdominoplasty*
;
Body Mass Index
;
Chemoprevention
;
Drainage
;
Enoxaparin
;
Hematoma
;
Hemostasis
;
Humans
;
Mortality
;
Pulmonary Embolism
;
Risk Assessment
;
Risk Factors
;
Surgery, Plastic
;
Thromboembolism
;
Thrombosis
;
Venous Thromboembolism
;
Venous Thrombosis
3.Thromboprophylaxis in Abdominoplasty: Efficacy and Safety of a Complete Perioperative Protocol.
Giovanni Francesco MARANGI ; Francesco SEGRETO ; Igor POCCIA ; Stefano CAMPA ; Daniele TOSI ; Daniela LAMBERTI ; Paolo PERSICHETTI
Archives of Plastic Surgery 2016;43(4):360-364
BACKGROUND: Venous thromboembolism, a spectrum of diseases ranging from deep venous thrombosis to pulmonary embolism, is a major source of morbidity and mortality. The majority of cases described in plastic surgery involve abdominoplasty. Risk assessment and prophylaxis are paramount in such patients. General recommendations were recently developed, but the evidence in the literature was insufficient to prepare exhaustive guidelines regarding the medication, dosage, timing, or length of the prophylaxis. METHODS: A thromboprophylaxis protocol was developed for patients undergoing abdominoplasty. The protocol consisted of preoperative, intraoperative, and postoperative measures. Enoxaparin was administered as chemoprophylaxis in selected patients. The study involved 253 patients. The patients were analyzed for age, body mass index, enoxaparin dosage, risk factors, and complications. RESULTS: Deep venous thrombosis was documented in two cases (0.8%). No pulmonary embolism occurred. Three patients (1.2%) presented mild subcutaneous abdominal hematoma within the first postoperative week that spontaneously resorbed with neither aesthetic nor functional complications. Two patients (0.8%) presented severe hematoma requiring surgical re-intervention for drainage and hemostasis revision. Statistical analysis showed no significant correlation between enoxaparin dosage and hematoma (P=0.18) or deep venous thrombosis (P=0.61). CONCLUSIONS: The described thromboprophylaxis protocol proved to be effective in the prevention of thrombotic events, with an acceptable risk of hemorrhagic complications. Furthermore, it provides new evidence regarding the currently debated variables of chemoprophylaxis, namely type, dosage, timing, and length.
Abdominoplasty*
;
Body Mass Index
;
Chemoprevention
;
Drainage
;
Enoxaparin
;
Hematoma
;
Hemostasis
;
Humans
;
Mortality
;
Pulmonary Embolism
;
Risk Assessment
;
Risk Factors
;
Surgery, Plastic
;
Thromboembolism
;
Thrombosis
;
Venous Thromboembolism
;
Venous Thrombosis
4.Hidden Sentinel Node in Cutaneous Melanoma.
Francesco SEGRETO ; Daniele TOSI ; Giovanni Francesco MARANGI ; Alfonso Luca PENDOLINO ; Stefano SANTORO ; Pierluigi GIGLIOFIORITO ; Paolo PERSICHETTI
Archives of Plastic Surgery 2013;40(5):642-644
No abstract available.
Melanoma
;
Nitriles
;
Pyrethrins
5.Use of platelet-rich plasma and modified nanofat grafting in infected ulcers: Technical refinements to improve regenerative and antimicrobial potential
Francesco SEGRETO ; Giovanni Francesco MARANGI ; Carolina NOBILE ; Mario ALESSANDRI-BONETTI ; Chiara GREGORJ ; Vincenzo CERBONE ; Marco GRATTERI ; Erika CALDARIA ; Maria Cristina TIRINDELLI ; Paolo PERSICHETTI
Archives of Plastic Surgery 2020;47(3):217-222
Background:
Surgical reconstruction of chronic wounds is often infeasible due to infection, comorbidities, or poor viability of local tissues. The aim of this study was to describe the authors’ technique for improving the regenerative and antimicrobial potential of a combination of modified nanofat and platelet-rich plasma (PRP) in nonhealing infected wounds.
Methods:
Fourteen patients met the inclusion criteria. Fat tissue was harvested from the lower abdomen following infiltration of a solution of 1,000 mL of NaCl solution, 225 mg of ropivacaine, and 1 mg of epinephrine. Aspiration was performed using a 3-mm cannula with 1-mm holes. The obtained solution was decanted and mechanically emulsified, but was not filtered. Non-activated leukocyte-rich PRP (naLR-PRP) was added to the solution before injection. Patients underwent three sessions of injection of 8-mL naLR-PRP performed at 2-week intervals.
Results:
Thirteen of 14 patients completed the follow-up. Complete healing was achieved in seven patients (53.8%). Four patients (30.8%) showed improvement, with a mean ulcer width reduction of 57.5%±13.8%. Clinical improvements in perilesional skin quality were reported in all patients, with reduced erythema, increased thickness, and increased pliability. An overall wound depth reduction of 76.6%±40.8% was found. Pain was fully alleviated in all patients who underwent re-epithelization. A mean pain reduction of 42%±33.3% (as indicated by visual analog scale score) was found in non-re-epithelized patients at a 3-month follow-up.
Conclusions
The discussed technique facilitated improvement of both the regenerative and the antimicrobial potential of fat grafting. It proved effective in surgically-untreatable infected chronic wounds unresponsive to conventional therapies.